naringenin has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, G; Han, X; Jin, L; Liang, W; Song, Z; Zhang, H | 1 |
| Carroll, KK; Chambers, AF; Guthrie, N; Moussa, M; So, FV | 1 |
2 other study(ies) available for naringenin and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Naringenin: a potential immunomodulator for inhibiting lung fibrosis and metastasis.
Topics: Animals; Bleomycin; Carcinoma, Lewis Lung; Cell Line, Tumor; Down-Regulation; Female; Flavanones; Forkhead Transcription Factors; Immunologic Factors; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pulmonary Fibrosis; T-Lymphocytes, Regulatory; Transforming Growth Factor beta1 | 2009 |
Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Beverages; Breast Neoplasms; Cell Division; Citrus; Female; Flavanones; Flavonoids; Genistein; Hesperidin; Humans; Isoflavones; Mammary Neoplasms, Experimental; Quercetin; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured | 1996 |